Disease | carcinoid syndrome |
Phenotype | C0206754|neuroendocrine tumour |
Sentences | 2 |
PubMedID- 24463166 | [treatment of metastatic midgut neuroendocrine tumour associated with carcinoid syndrome]. |
PubMedID- 22119496 | Interpretation: everolimus plus octreotide lar, compared with placebo plus octreotide lar, improved progression-free survival in patients with advanced neuroendocrine tumours associated with carcinoid syndrome. |
Page: 1